Can Splenic Characteristics Predict Rectal Cancer Chemotherapy Toxicity and Treatment Outcomes in Rectal Cancer Patients?
Oncology · 24.03.2026 · 1-8
DOI: 10.1159/000551703 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology, online erschienen am 24.03.2026. Verfasst von Lara Wirth und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Western Precinct, The University of Melbourne, Melbourne, Victoria, Australia, lwirth@student.unimelb.edu.au. Hauptthemen laut MEDLINE: Rectal Neoplasms, Tomography, X-Ray Computed, Spleen, Antineoplastic Agents. Die Arbeit nennt 22 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Introduction
Rectal cancer requires multidisciplinary management, including chemotherapy treatment, for successful clinical outcomes. Splenic characteristics on computed tomography (CT) imaging have been proposed to reflect immune function. This study explores whether splenic size and density on pretreatment CT scans predicts chemotherapy dose-limiting toxicities (DLTs) and cancer outcomes in rectal cancer patients.
Methods
A retrospective study of rectal cancer patients who received chemotherapy treatment with curative intent from February 2013 to March 2023 was conducted. Pretreatment CT scans were collected for measurement of splenic volume and density. Receiver operating characteristics analyses of splenic density and volume was performed to calculate the area under the curve (AUC). The AUC was used to determine association with overall survival (OS), disease-free survival (DFS), and DLT.
Results
A total of 234 patients were included, and 98 (41.8%) patients were classified as having diffuse reduction of spleen density (DROSD). The DROSD group experienced significantly reduced DLTs (13.3% vs. 24.3%, p = 0.045). There was no significant association between OS or DFS with splenic volume or density.
Conclusion
This study has shown that DROSD is an independent predictive factor for reduced DLT in rectal cancer patients undergoing chemotherapy treatment. Further research is needed to validate findings and elucidate underlying mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Western Precinct, The University of Melbourne, Melbourne, Victoria, Australia, lwirth@student.unimelb.edu.au.
- Department of Surgery, Western Precinct, The University of Melbourne, Melbourne, Victoria, Australia.
- Melbourne Academic Centre for Health, North Melbourne, Victoria, Australia.
- Department of Colorectal Surgery, Footscray Hospital, Western Health, Melbourne, Victoria, Australia.
Zitieren
APA
Wirth, L., Besson, A., Hudson, P., Yeung, J., & Yeung, J. M. (2026). Can Splenic Characteristics Predict Rectal Cancer Chemotherapy Toxicity and Treatment Outcomes in Rectal Cancer Patients?. Oncology, 1-8. https://doi.org/10.1159/000551703
Vancouver
Wirth L, Besson A, Hudson P, Yeung J, Yeung JM. Can Splenic Characteristics Predict Rectal Cancer Chemotherapy Toxicity and Treatment Outcomes in Rectal Cancer Patients?. Oncology. 2026:1-8. doi:10.1159/000551703
BibTeX
@article{Wirth2026,
author = {Wirth, Lara and Besson, Alex and Hudson, Paige and Yeung, Josephine and Yeung, Justin M},
title = {Can Splenic Characteristics Predict Rectal Cancer Chemotherapy Toxicity and Treatment Outcomes in Rectal Cancer Patients?},
journal = {Oncology},
year = {2026},
pages = {1--8},
doi = {10.1159/000551703}
}
EUVIMED